DermaZinc Spray, 0.25% zinc pyritione, topical OTC, 4 fl oz bottle Distributed By: Dermallogix Partners, Inc. Scarborough, ME 04070
Published June 20, 2012 · Recall initiated: March 20, 2012
Summary
FDA records drug Class III recall D-1380-2012, published June 20, 2012 and initiated March 20, 2012. Recalling firm: Quadrant Chemical Corporation; Status: Terminated; Reported quantity: 4800 bottles; Lot: Lot 022110-01. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent (Single Ingredient Drug): The firm is recalling the product because the product is subpotent and does not meet the labeled 0.25% zinc pyrithione level.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Quadrant Chemical Corporation
- Distributor
- Maine
- Lot
- Lot 022110-01
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAArthrotec 75 (diclofenac sodium and misoprostol) tablets, 75 mg/200 mcg, a) 30-count tablets per bottle (NDCJune 20, 2012
- FDAEndocet (oxycodone and acetaminophen) tablets, USP, 10 mg/650 mg, 100-count tablets per bottle, Rx only,June 20, 2012
- FDACONCENTRATED SODIUM CHLORIDE INJECTION, USP, 23.4% a) 30 mL SINGLE DOSE VIAL, (NDC 0517-2930-25), b) 100 mLJune 20, 2012
- FDAPropofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patientJune 20, 2012
- FDAOctreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL singleJune 20, 2012
- FDAAlsoSalt Sodium Free Butter flavored Salt Substitute, 2.5 oz. bottleJune 20, 2012
Questions about this recall
Was DermaZinc Spray, 0.25% zinc pyritione, topical OTC, 4 fl oz bottle Distributed By: Dermallogix Partners, Inc. Scarborough, ME 04070 recalled?
Yes. FDA published recall D-1380-2012 on June 20, 2012. Reported hazard: Subpotent (Single Ingredient Drug): The firm is recalling the product because the product is subpotent and does not meet the labeled 0.25% zinc pyrithione level.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail